Figure 3
Evaluation and verification of the prognostic costimulatory molecule-related lncRNA signature. Kaplan–Meier survival curves for high- and low-risk patients in training (A) and testing (D) cohorts. Distribution and survival status of HCC patients with different risk scores. A heatmap showing the expression levels of five prognostic costimulatory molecule-related lncRNAs in the high- and low-risk groups in training (B) and testing (E) cohorts. Time-dependent ROC curves of the prognostic signature in training (C) and testing (F) cohorts. (G, H) Univariate and multivariate Cox regression analyses for the risk score as an independent prognostic factor.
